Literature DB >> 10946266

Break of T cell ignorance to a viral antigen in the liver induces hepatitis.

D Voehringer1, C Blaser, A B Grawitz, F V Chisari, K Buerki, H Pircher.   

Abstract

To study peripheral tolerance of CD8 T cells to a classically MHC-restricted peptide Ag expressed in hepatocytes, ALB1 transgenic (tg) mice expressing the CTL epitope GP33 of the lymphocytic choriomeningitis virus glycoprotein under control of the mouse albumin promoter were generated. ALB1 mice exclusively expressed the GP33 transgene in the liver and, at a 100- to 1000-fold lower level, in the thymus. TCR-tg mice specific for the GP33 epitope were used to directly follow GP33-specific T cells in vivo. These experiments revealed that 1) thymic expression of the GP33 transgene led to incomplete central deletion of TCR-tg cells; and 2) peripheral TCR-tg cells in ALB1 mice ignored the GP33 transgene expressed in hepatocytes. Ignorance of adoptively transferred TCR-tg cells in ALB1 mice was broken by infection with lymphocytic choriomeningitis virus, leading to induction of hepatitis in ALB1, but not in control, mice. Taken together, we have established a novel model of virus-induced CD8 T cell-mediated autoimmune hepatitis in mice and demonstrate that naive CD8 T cells may ignore Ags expressed in the liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946266     DOI: 10.4049/jimmunol.165.5.2415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling.

Authors:  Karl S Lang; Panco Georgiev; Mike Recher; Alexander A Navarini; Andreas Bergthaler; Mathias Heikenwalder; Nicola L Harris; Tobias Junt; Bernhard Odermatt; Pierre-Alain Clavien; Hanspeter Pircher; Shizuo Akira; Hans Hengartner; Rolf M Zinkernagel
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

2.  High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?

Authors:  S Berardi; F Lodato; A Gramenzi; A D'Errico; M Lenzi; A Bontadini; M C Morelli; M R Tamè; F Piscaglia; M Biselli; C Sama; G Mazzella; A D Pinna; G Grazi; M Bernardi; P Andreone
Journal:  Gut       Date:  2006-06-23       Impact factor: 23.059

3.  Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patients.

Authors:  Chenliang Zhou; Chaofan Li; Guo-Zhong Gong; Shuang Wang; Ji-Ming Zhang; Dao-Zhen Xu; Li-Min Guo; Hong Ren; Min Xu; Qing Xie; Chen Pan; Jie Xu; Zhongyu Hu; Shuang Geng; Xian Zhou; Xianzheng Wang; Xiaoyu Zhou; Haili Mi; Gan Zhao; Wencong Yu; Yu-Mei Wen; Lihua Huang; Xuan-Yi Wang; Bin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-06-30       Impact factor: 3.452

Review 4.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

5.  Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.

Authors:  J Satoi; K Murata; M Lechmann; E Manickan; Z Zhang; H Wedemeyer; B Rehermann; T J Liang
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses.

Authors:  Szun Szun Tay; Yik Chun Wong; David M McDonald; Nicole A W Wood; Ben Roediger; Frederic Sierro; Claire Mcguffog; Ian E Alexander; G Alex Bishop; Jennifer R Gamble; Wolfgang Weninger; Geoffrey W McCaughan; Patrick Bertolino; David G Bowen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

7.  New horizon for radical cure of chronic hepatitis B virus infection.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2016-07-28

8.  Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).

Authors:  Elena Lorente; Miguel G Fontela; Eilon Barnea; Antonio J Martín-Galiano; Carmen Mir; Begoña Galocha; Arie Admon; Pilar Lauzurica; Daniel López
Journal:  Mol Cell Proteomics       Date:  2020-04-07       Impact factor: 5.911

9.  Hepatitis resulting from liver-specific expression and recognition of self-antigen.

Authors:  James Buxbaum; Peiqing Qian; Paul M Allen; Marion G Peters
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

10.  T-cell reconstitution without T-cell immunopathology in two models of T-cell-mediated tissue destruction.

Authors:  Pablo Penaloza-MacMaster; David Masopust; Rafi Ahmed
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.